Biotissue Holdings, Inc. 近日宣布，已将其手术与伤口护理业务出售给BioStem Technologies, Inc.。此举标志着Biotissue Holdings将进一步集中资源，深化其在眼科创新领域的战略布局。通过剥离非核心业务，公司旨在更专注于眼科技术的研发与商业化，以巩固其在专业市场的领先地位。
Biotissue Holdings, Inc. 近日宣布，已将其手术与伤口护理业务出售给BioStem Technologies, Inc.。此举标志着Biotissue Holdings将进一步集中资源，深化其在眼科创新领域的战略布局。通过剥离非核心业务，公司旨在更专注于眼科技术的研发与商业化，以巩固其在专业市场的领先地位。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.